Dreamcatcher Alpacas

Research: Alpaca nanobodies in medicine

PubMed indexes about 702 studies on alpaca nanobodies in medicine in alpacas. These are the most relevant, with open-access links where available.

Updated 2026-10-02By the Dreamcatcher Alpacas editorial team
  1. Nanobodies: natural single-domain antibodies. Muyldermans S Annual review of biochemistry, 2013. PubMed 23495938 · DOI · cited 1774×
  2. Nanobodies: From High-Throughput Identification to Therapeutic Development. Fridy PC, Rout MP, Ketaren NE Molecular & cellular proteomics : MCP, 2024. PubMed 39433212 · DOI · Free full textOpen access · cited 40×
  3. Nanobody-based heavy chain antibodies and chimeric antibodies. Koch-Nolte F Immunological reviews, 2024. PubMed 39212236 · DOI · Free full textOpen access · cited 28×
  4. A robust pipeline for rapid production of versatile nanobody repertoires. Fridy PC, Li Y, Keegan S et al. Nature methods, 2014. PubMed 25362362 · DOI · Free full textOpen access · cited 473×
  5. A toolbox of anti-mouse and anti-rabbit IgG secondary nanobodies. Pleiner T, Bates M, Görlich D The Journal of cell biology, 2018. PubMed 29263082 · DOI · Free full textOpen access · cited 140×
  6. From discovery to the clinic: structural insights, engineering options, clinical, and 'next wave' applications of camelid-derived single-domain antibodies. Evers A, Guarnera E, Pekar L et al. mAbs, 2025. PubMed 41193399 · DOI · Free full textOpen access · cited 17×
  7. Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bites. Ahmadi S, Burlet NJ, Benard-Valle M et al. Nature, 2025. PubMed 41162699 · DOI · Free full textOpen access · cited 27×
  8. A nanobody-based therapeutic targeting Nipah virus limits viral escape. Isaacs A, Nieto GV, Zhang X et al. Nature structural & molecular biology, 2025. PubMed 40629166 · DOI · cited 7×
  9. Generation of glycan-specific nanobodies. Khilji SK, Goerdeler F, Frensemeier K et al. Cell chemical biology, 2022. PubMed 35705094 · DOI · cited 22×
  10. Single-Domain Antibodies for Intracellular Toxin Neutralization. Czajka TF, Mantis NJ Methods in molecular biology (Clifton, N.J.), 2022. PubMed 35157289 · DOI · cited 4×
  11. Development and Characterization of Nanobodies Targeting the Kupffer Cell. Zheng F, Zhou J, Ouyang Z et al. Frontiers in immunology, 2021. PubMed 33692811 · DOI · Free full textOpen access · cited 11×
  12. Novel single-domain antibodies targeting a unique transferrin receptor 1 epitope for cross-species delivery of drugs in the central nervous system. David M, Cohen R, Beuzelin D et al. Journal of controlled release : official journal of the Controlled Release Society, 2025. PubMed 41110474 · DOI · cited 1×
  13. Llama DNA Immunization and Isolation of Functional Single-Domain Antibody Binders. Trempe F, Rossotti MA, Maqbool T et al. Methods in molecular biology (Clifton, N.J.), 2022. PubMed 35157268 · DOI · cited 7×
  14. Immunogenicity Risk Profile of Nanobodies. Ackaert C, Smiejkowska N, Xavier C et al. Frontiers in immunology, 2021. PubMed 33767701 · DOI · Free full textOpen access · cited 183×
  15. Nanobodies against Pfs230 block Plasmodium falciparum transmission. Dietrich MH, Gabriela M, Reaksudsan K et al. The Biochemical journal, 2022. PubMed 36520108 · DOI · Free full textOpen access · cited 28×

Bibliographic data from NCBI PubMed; citation counts and open-access status from Europe PMC.